CTIS.eu › Cities › Finland › Turku
Turku
Finland
286 total trials
111 recruiting
2023-504214-30-00
5
2024-06-27
Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
2023-503697-21-01
5
2024-06-24
Idiopathic pulmonary fibrosis
2023-505000-27-01
4
2023-12-29
newly diagnosed pediatric FLT3-ITD positive and NPM1 wild-type AML
2022-502623-22-00
1
2023-09-18
Metastatic castration-resistant prostate cancer
2022-502503-30-00
5
2022-12-15
Acute lymphoblastic leukemia
2024-517606-29-00
5
2020-10-30
Central retinal artery occlusion
2025-523552-31-00
5
2026-05-07
Systemic Lupus Erythematosus
2025-521560-36-00
4
2026-04-22
Type 1 Diabetes
2025-520584-41-00
3
2026-03-10
Metabolism dysfunction
2024-518777-34-00
5
2026-02-11
B7-H4-Selected Advanced/Metastatic Endometrial Cancer.
2024-519369-24-00
5
2026-01-29
METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
2025-522390-11-00
4
2026-01-29
Peripheral arterial occlusive disease (PAOD)
2022-503070-36-00
5
2025-12-23
Group B streptococcus (GBS) disease
2024-513586-39-00
5
2025-12-10
Prostate Cancer
2025-520730-28-00
4
2025-12-08
Common EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung
2025-521281-97-00
5
2025-12-02
Non-Small Cell Lung Cancer (NSCLC)
2024-517614-14-00
4
2025-11-28
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2025-520747-32-00
5
2025-10-29
Mild to moderate Alzheimer’s Disease
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
2024-519152-82-00
5
2025-09-03
Relapsed/Refractory Follicular Lymphoma
2024-519331-42-00
5
2025-08-22
pMMR endometrial carcinoma
2024-511073-29-00
3
2025-06-13
Narcolepsy
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
2023-508196-36-00
4
2025-05-27
Follicular lymphoma
Showing 49–72 of 286 trials